Statin withdrawal and treating COVID-19 patients.
Pharmacol Res Perspect
; 9(6): e00861, 2021 12.
Article
in En
| MEDLINE
| ID: mdl-34708573
Most but not all observational studies of statin treatment of COVID-19 patients suggest that treatment improves outcomes. However, almost all of these studies fail to consider that withdrawing statins after hospital admission may have detrimental effects, a finding which cardiovascular investigators have known for 15-20 years. Continuing or starting statin treatment after hospital admission consistently improves cardiovascular outcomes. Similarly, inpatient statin treatment of COVID-19 improves survival. For this reason, observational studies of the effectiveness of outpatient-documented statin treatment of COVID-19 patients must consider the negative consequences of statin withdrawal after hospital admission.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Hydroxymethylglutaryl-CoA Reductase Inhibitors
/
COVID-19 Drug Treatment
Type of study:
Observational_studies
/
Systematic_reviews
Limits:
Humans
Language:
En
Journal:
Pharmacol Res Perspect
Year:
2021
Document type:
Article
Affiliation country:
France
Country of publication:
United States